Skip to main content
. 2018 Jul 27;12(1):92–100. doi: 10.1093/ckj/sfy060

FIGURE 1.

FIGURE 1

Changes in proteinuria and renal function in a diabetic (Patient 1) treated with bevacizumab. (A) Serum creatinine (μmol/L and mg/dL) and eGFR (by Cockroft–Gault, non-African American, in mL/min versus date). (B) ACR (μg albumin/mg creatinine) (equivalent to 0.001 g/g creatinine) versus date. Black arrow and line shows the period of bevacizumab injections (10 injections of 1.25 mg; total = 12.5 mg).